IVIVC (In vitro-in vivo correlation) is a desired feature in the practice of drug dissolution testing. An appropriate IVIVC provides credibility to an in vitro dissolution test by avoiding false-negative indications concerning the quality and manufacturing of a product. In addition, it further enhances economic benefits to the manufactures by providing efficient development and modification of products, thus obtaining regulatory approvals.
Developing an IVIVC may be considered a two-part process: (1) analyzing the in vitro dissolution data and relating it to in vivo results. This has been the subject of the last few posts (1, 2, 3); (2) conducting an actual dissolution test for generating appropriate data. This post is regarding the latter aspect.
For an appropriate dissolution test, in general, and particularly for developing IVIVC, one must conduct the test selecting experimental conditions to simulate an in vivo environment as closely as possible. Commonly the following experimental conditions should be considered in this regard.
- A dissolution medium should be an aqueous solution having a pH in the range of 5-7 and be maintained at 37C. The expected amount of the drug present in the product must be able to freely dissolve in the volume of the medium used, often 900 mL. If the drug is not freely soluble in water, then small amounts of a solubilizing agent such as SLS may be used.
- The dissolution medium should not be de-aerated. Instead, preference should be given that the medium equilibrated at 37C with dissolved air/gasses, particularly for IVIVC studies.
- An apparatus should be selected to have an appropriate mechanism to provide thorough but gentle mixing and stirring for an efficient product/medium interaction. The use of sinkers may be avoided as these often alter the dissolution characteristics of the test products. Paddle and basket apparatuses are known for their inefficient stirring and mixing. Thus their use should be critically evaluated before use for IVIVC studies.
- Frequent samples (8-10) should be withdrawn to obtain a smooth dissolution profile leading to complete dissolution within the dosing interval of the test product in humans.
- If the dissolution results are not as expected, then the product/formulation should be modified to obtain the product’s desired/expected release characteristics. However, altering experimental conditions such as medium, apparatus, rpm, etc., should be avoided as these are generally linked to GI physiology which remains the same for the test to test or product to product. Therefore, obtaining dissolution results by altering testing (experimental) conditions may void the test for IVIVC purposes.